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East China Sea is one of the four sea areas in China, which possesses peculiar ecological environment and many kinds of
living creatures, especially the microorganisms. We established the East China Sea microorganism library (during 2006–2010)
for the ﬁrst time, which stored about 30000 strains that covered most kinds of the species. In this paper, 395 pure strains of
East China Sea microorganism library which belong to 33 diﬀerent genera were mainly introduced. Sulﬁtobacter, Halomonas,
Bacillus, Pseudoalteromonas,a n dIdiomarina were the most dominant species. On the large-scale biological activity screening of
the 395 strains, 100 strains possess diﬀerent biological activities based on diﬀerent screening models, of which 11.4% strains
have antibacterial activities, 15.9% have cytotoxicity activities, and 6.1% have antioxidation activities. Besides, the secondary
metabolitesof6strainswithstrongbiologicalactivitieswerestudiedsystematically;diketopiperazinesandmacrocycliclactonesare
the active secondary metabolites. The species and the biological activity of microorganisms diversity, the abundant structure type
of the secondary metabolites, and their bioactivities all indicate that East China Sea is a potent marine microorganisms-derived
developing resource for drug discovery.
1.Introduction
Since the Scottish scientist Alexander Fleming discovered
penicillin from the penicillum fungi in 1929, bioactive
secondary metabolites isolated from the microorganisms
havebeentheabundantresourcesforthedrugdiscovery.The
traditional sources of bioactive compounds were terrestrial
microorganisms which could be easily obtained and readily
explored. In comparison, the ocean source was scarcely
studied. However, since the 1970s, as a consequence of the
advanced technology, the ocean has become an attracting
area of drug development because of the structural diversity
and pharmacological potential which were presented by the
novel scaﬀold molecules isolated from this environment [1].
In 2009, scientists wrote a report that the distribution by
phylum for 2006 and 2007 is compared with the historic
average derived for the period 1965–2005, the production
of marine natural products of microorganisms took a
spectacular rise, especially the fungi and bacteria of marine
origin [2]. It had also been known that the geographic
region of collection sources in output mainly focused on
the Caribbean, the China Sea, the Indian Ocean, Japan, and
the Western Paciﬁc. The emergence of the China Sea as a
signiﬁcant source of new compounds is particularly obvious.
China is a vast ocean country, which includes four sea
areas, such as Bohai Sea, Yellow Sea, South China Sea, and
East China Sea. Our country possesses coastline of 18,000
kilometers and the island coastline of 14,000 kilometers, and
hasthesovereigntyandjurisdictionovertheseaareaofabout
3 million square kilometers spanning the tropical zone, sub-
tropical zone, temperate zone, and cold zone. Besides, China
Sea possesses four kinds of marine ecosystems, including
coastal wetland ecosystems, coral reef ecosystems, upwelling
ecosystems, and deep sea ecosystems, which produce many
kinds of microorganisms and have abundant resources. The
rest three sea areas, except for East China Sea, have been
systematically studied [3, 4], while microbial resources of the
large-scale survey and the study of the strains with biological
activities in the East China Sea have not been reported.
East China Sea mainly has the upwelling ecosystems
and deep sea ecosystems. On one hand, upwelling marine
ecosystem possesses higher biological diversity than other
ecosystem because of the rich nutrients; on the other hand,
some animals and microorganisms with speciﬁc structures2 Evidence-Based Complementary and Alternative Medicine
mainly exist in the deep-sea ecosystem. Overall, the East
China Sea has great potential for drug development because
of its rich and unique microbial resources.
In order to discover the bioactive secondary metabolites
of the microorganisms from the East China Sea, it is essential
to do the large-scale survey of the microbial resources
of East China Sea. In this paper, we mainly reported the
marine microorganisms, their biological activities such as
antimicrobial, antitumor, antioxidant activities, and some
secondary metabolites of the strains with biological activities
in the East China Sea.
2.MaterialsandMethods
2.1. Sampling. The sea water and sea sediment samples were
collected in 2006 at a depth of 30m in the East China Sea
(27◦15 50   N120◦45 22   E ∼ 31◦24 7   N122◦40 48   E),
and we totally obtained 100 sea sediment sample and 122
sea water sample, which were all stored in refrigerator at
−80◦C. Weigh 5g sea sediment, add 45mL sterile artiﬁcial
water, shake and mix fully, and stand settlement. Sterile
sea water and the supernatant of the sea sediment were
progressively diluted with sterilized artiﬁcial seawater step by
step into 10−1,1 0 −2,1 0 −3,1 0 −4,a n d1 0 −5. Take 0.2mL every
gradient diluent and spread them into diﬀerent medium
plates, incubate at 25◦C for 7–14 days, and then pick the
single colony according to the diﬀerences of the sample
and the morphological of the strains. Streak plate method
combined with the microscope observation is used during
the separation process. All these pure strains were now
conserved by freezing at −80◦Ca n da t4 ◦C in our laboratory.
2.2. Determination of 16S rRNA Sequence. According to the
method described by Rainey et al. [5], the genomic RNAs
of all the pure strains were prepared by Genomic RNA
Isolation kit (Watson). Then, gene encoding 16S rRNA was
ampliﬁed by PCR with 16S rRNA Bacterial Identiﬁcation
PCR kit (TaKaRa). An ABI BigDye and Terminator 3.1 cycle
sequencing kit (Applied Biosystems) and an automated RNA
sequencer (model ABI 3730; Applied Biosystems) were used
to determine 16S rRNA gene sequence.
2.3. Activity Assays
2.3.1.AssayofAntibacterialActivities. Allstrainswererespec-
tively inoculated in tubes containing 5mL corresponding
liquid medium and cultured on a rotary shaker (150rpm)
at 28◦Cf o r3∼ 5 days. The fermented broth was ﬁltered
through cheese cloth to separate the supernatant and thallus.
Antibacterial activity of all the supernatants was evaluated
by zone of inhibition using the agar well diﬀusion assay. The
indicator strains are B. subtilis (ATCC 6633), E. coli (ATCC
25922), and S. aureus (ATCC 25923). In this part, ampicillin
and blank medium were used as the positive and negative
control, respectively.
2.3.2.AssayofCytotoxicActivities. Theentiresupernatantsof
cultured broth were prepared as described above. Cytotoxic
activities of these supernatants were evaluated by MTT
method [6] using HepG2, HL-60, SMMC 7721, MCF, P388,
S180, and SW1990 celllines. In MTTassay, the cell lines were
grown in RPMI-1640 supplemented with 10% fetal bovine
serum (FBS) under a humidiﬁed atmosphere of 5% CO2
and 95% air at 37◦C. Cell suspension (90µL) at a density
of 5 × 104 cell/mL was plated in 96-well microtiter plates
and incubated for 24h under the mentioned condition. The
supernatants (10µL) of cultured broth was added to each
well and further incubated for additional 72h in the same
condition. Then, 10µLo fM T Ts o l u t i o n( 5m g / m Li nI P M I -
1640 medium) was added to each well and incubated for
4h. The old medium (110µL) containing MTT in 96-well
microtiter plates was gently replaced by DMSO and pipetted
to dissolve any formazan crystals. Absorbance was then
determined on a Spectra Max Plus plate reader at 540nm.
In this part, actinomycin D was used as the positive control,
normal saline was used as negative control, and 10% DMSO
solution was used as blank control.
2.3.3. Assay of Antioxidant Activities. Seed culture (50mL) of
all strains was inoculated into Erlenmeyer ﬂask (2000mL)
containing the liquid medium (500mL) and cultured on a
rotary shaker (150rpm) at 28◦Cf o r5d a y s .T h ef e r m e n t e d
whole broth was centrifugated at 12000rpm for 5min and
separated from supernatant and thallus. The supernatant
was extracted with ethyl acetate for 3 times, and the
combined extracts were evaporated in vacuum at 30◦Ct o
dryness to yield the crude extract, which was dissolved at a
concentration of 1mg/mL in methanol for further analyses.
The DPPH assay was evaluated according to the method
described by Hu and Kitts [7] with a little modify. Brieﬂy,
crude extract in methanol solution (0.3mL) mixed with
0.06mmol/L DPPH (0.5mL) dissolving in ethanol solution
and stood at room temperature in the dark for 20min when
the absorbance at 517nm was taken. Capacity of free-radical
scavenging was evaluated by the inhibition percentage,
calculated from the following equation: Inh% = [(Acontrol−
Asample)/Acontrol] × 100, where Acontrol = absorbance of
0.06mmol/L DPPH (0.5mL) with methanol (0.3mL),
Asample = absorbance of 0.06mmol/L DPPH (0.5mL) with
sample solution (0.3mL).
The ABTS assay was evaluated according to the method
of Kajal and Paulraj [8] with a little modify. Brieﬂy, a stock
solution of ABTS radical cation was prepared by dissolving
ABTS (0.25mmol/L, 5mL in water) with potassium persul-
fate (2mmol/L, 88mL). The reaction mixture was diluted
to 25 times volume with EtOH and left to stand at room
temperature overnight (13h) in the dark. The ABTS assay
was started by mixing the diluted ABTS solution (0.9mL)
with crude extract in methanol solution (0.1mL) and stood
at room temperature in the dark for 20min when the
absorbance at 734nm was taken. Capacity of free-radical
scavenging was evaluated by the inhibition percentage,
calculated from the following equation; Inh% = [(Acontrol−
Asample)/Acontrol]×100,whereAcontrol =absorbanceofdiluted
ABTS solution (0.9mL) with methanol (0.1mL), Asample =
absorbance of diluted ABTS solution (0.9mL) with sample
solution (0.1mL). Quercetin was used as positive control in
the two tests.Evidence-Based Complementary and Alternative Medicine 3
Table 1: Taxonomy of 395 strains.
Genus No. Genus No. Genus No.
Agrococcus 8 Alcanivorax 3 Alphaproteobacterium 4
Bacillus 30 Brachybacterium 7 Brevibacterium 6
Dietzia 2 Erythrobacter 1 Exiguobacterium 10
Gamma proteobacterium 5 Halomonas 42 Idiomarina 36
Kocuria 9 Kurthia 2 Loktanella 3
Lysobacter 2 Marinobacter 4 Marinococcus 3
Methylarcula 5 Micrococcus 1 Oceanicola 4
Paracoccus 6 Photobacterium 7 Planococcus 5
Pseudoalteromonas 69 Pseudomonas 12 Psychrobacter 2
Rheinheimera 5 Salegentibacter 2 Staphylococcus 10
Sulﬁtobacter 62 Vibrio 8 Virgibacillus 20
2.4. Fermentation of the Pure Cultured Strains. The strains
F81612, F201721, F8712, F321122, F121122, and M44 have
been isolated from sea sediment and sea water of East China
Sea, respectively. They were all isolated on F1 medium with
incubationat28◦C.F1Medium:Glucose(6g),peptone(5g),
and yeast extract (1g) were dissolved in artiﬁcial seawater
(1L).Astatisticalmethodology,combiningPlackett-Burman
design (PBD) with response surface methodology (RSM),
was applied to optimize the biological activity of the strains
inthefermentation[9].Eachstrainwasfermentedasfollows:
40 2L Erlenmeyer ﬂasks each containing 700mL F1 medium
(set to the pH 6.5 before sterilization) were inoculated and
grown for 4 ∼ 7d a y sa t2 8 ◦C while shaking at 90rpm.
2.5. Isolation of the Secondary Metabolites. The 6 entire cul-
ture broths were all centrifugated at 12000rpm for 15 min-
utes,respectively,gotthesupernatants.Theeachsupernatant
was extracted with ethyl acetate for 3 times. The combined
extracts were evaporated in vacuum at 30◦Ct od r y n e s st o
yield crude extract. Then, the each crude extract was sub-
jected to Sephadex LH-20 and silica gel column, middle-
pressure LC with the gradient elution, and chromatographed
on preparative HPLC columns repeatedly, which yielded
many secondary metabolites.
3. Results
3.1. Taxonomy of the Studied Pure Strains. The 16S rRNA
gene sequence has been determined for a large number
of strains. GenBank, the largest databank of nucleotide
sequences, has over 20 million deposited sequences, of which
over 90,000 are of 16S rRNA gene. This means that there
are many previously deposited sequences against which to
compare the sequence of an unknown strain [10]. 16S rRNA
sequences of 416 pure strains have been determined. After
blasting with the GenBank sequences, it is known that a
total of 395 strains can be determined their taxonomic status
(Table 1). 395 strains belong to 33 diﬀerent genera, which
Sulﬁtobacter, Halomonas, Bacillus, Pseudoalteromonas,a n d
Idiomarina were the most dominant species.
3.2. Antibacterial Activities. 45 strains of the tested pure
isolated microorganisms exhibited antibacterial activities,
among of which most strains belong to the Bacillus, Sulﬁ-
tobacter,a n dPseudoalteromonas (Table 2). The antibacterial
activities of marine Bacillus mainly focused on the killing
S.aureus and B.subtilis, while the Sulﬁtobacter mainly showed
the strong activities of killing S.aureus,a n dPseudoal-
teromonas mainly showed the strong activities of killing
E.coli.
3.3. Cytotoxic Activities. The tested pure isolated microor-
ganisms exhibited good cytotoxicity activities to several cell
lines, like HepG2, Hela, MCF, and SMMC 7721. It means not
all the strains are susceptible to all the tested cell lines, which
signiﬁes the diﬀerences between the genus and the strains. 63
strains of the tested pure isolated microorganisms exhibited
cytotoxicity, among of which most strains were sensitive to
the HepG2 cell line and their inhibitory ratio mostly exceed
20% (Table 3).
Most strains of Sulﬁtobacter, Pseudoalteromonas,a n d
Halomonas exhibited good cytotoxic activities. For example,
Sulﬁtobacter sp. is the common species of pure cultured
strains. In this species, most strains show good cytotoxic
activities to HepG2 cell line (Figure 1). About 25% strains
of this species possess strong cytotoxicity activities, whose
inhibitory ratios exceed 30%, while the inhibitory ratios of
another 30% strains exceed 25%. Thus, it can be seen that
Sulﬁtobacter sp. is the potential ones which may produce
cytotoxic secondary metabolites.
3.4. Antioxidant Activities. The antioxidant activity of the
pure cultured strains was determined by the method of
spectrophotometry DPPH· radical scavenging assay and
ABTS·+ radical cation decolorization assay. We screened
395 fermented liquid extract of strains, among of which
24 strains show antioxidant activity using the DPPH·
radical scavenging assay, while 30 strains exhibit antioxidant
activity using the ABTS+· radical cation decolorization assay
(Figures 2 and 3). In the DPPH· assay, inhibitory ratio of
the 11 strains exceed 40%, and 3 strains exceed 90%. In
the ABTS·+ assay, inhibitory ratio of the 10 strains exceed
40%, among of which strain F7 has the highest inhibitory
ration 98.97%. It can be seen that strains F19, F12, and F23
all exhibit good antioxidant activity in the both methods,
which deduce that these 3 strains may have 2 antioxidant
mechanisms at least.4 Evidence-Based Complementary and Alternative Medicine
Table 2: Strains with strongest antibacterial activities.
Strain no. Genus E. coli B. subtilis S. aureus
ZJ8112 Pseudoalteromonas ++ −−
F121112 Pseudoalteromonas + −−
F8712 Halomonas −− −
F321122 Halomonas −− −
201721 Pseudoalteromonas ++ − +
XB16 Idiomarina −− −
MZ0306A2 Bacillus ++ + +
MZ0208A2 Bacillus − ++ +
MZ0204A3 Bacillus − ++
P3001 Bacillus − + +++
P4004A Bacillus − ++
P16006B Idiomarina − +++ −
P3009B Idiomarina − +++ −
P16011A Bacillus − + −
P16010C Halomonas − ++ −
P4004C Bacillus − ++ ++
XF22−2 Sulﬁtobacter −− ++
P4003B Sulﬁtobacter −− +
P12012B Sulﬁtobacter −− ++
Note: “+++”means the diameters of the inhibition zone exceeding 15mm; “++” means the diameters of the inhibition zone 10–15mm; “+” means the
diameter of the inhibition zone exceeding 6–10mm; “−”means no antibacterial activities.
Table 3: Strains with strongest cytotoxic activities of the 395 strains.
Strain no. Genus Sensitive tumor strain Inhibitory ratio
F321121 Halomonas SMMC 7721 17.6%
P12002 Sulﬁtobacter HeLa, MCF 35%, 12%
F81612 Bacillus HeLa, SW1990 39%, 9.3%
F81611 Bacillus HeLa 29.1%
P3001 Vibrio HepG2 28%
P3002 Rheinheimera HepG2, MCF 27%
P16006A Kocuria HepG2 29%
P16006B Idiomarina HepG2 32%
P16001 Halomonas HeLa, MCF 18.4%, 20.4%
P4003B Sulﬁtobacter HepG2, P388 31%, 7.9%
P12006A2 Sulﬁtobacter HepG2 31%
P4006B Marinobacter HepG2, P388 42%, 13%
MZ0206A2 Bacillus SMMC7721, S180 11%, 19%
MZ0208A2 Bacillus SMMC 7721 21%
P16003 Kocuria HepG2 23%
P4004B Idiomarina HepG2 31%
P12002 Idiomarina HepG2 28.7%
P12012B Sulﬁtobacter HepG2, SW1990 14.9%, 17%
P12004D Sulﬁtobacter HepG2, S180 16.7%, 23%
All the cultured broths of the strains were tested at a ﬁxed concentration 500µg/mL. Each experiment was repeated 3 times, and the inhibitory ratio was the
average of the 3 results.
3.5. The Study of the Secondary Metabolites of the Strains. In
our screening program for bioactive principles from marine
microorganisms, we pick up 6 strains (F81612, F201721,
F8712, F321122, F121122, and M44) of diﬀerent genus with
strong biological activities to study their bioactive secondary
metabolites(Table 4,Figure 4).These6strainsmainlybelong
t o3s p e c i e sw h i c hi sBacillus, Pseudoalteromonas,a n d
Sulﬁtobacter. From the isolated secondary metabolites, it
is known that: (1) the main type of the metabolites of
these species is cyclopeptide, especially cyclodipeptide, (2)
some strains have the common secondary metabolites, for
example, macrolactins, cylco(Phe-Ile), cylco(Pro-Ile), andEvidence-Based Complementary and Alternative Medicine 5
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Figure 1: Strains of Sulﬁtobacter sp. with cytotoxicity activities to
HepG2 cell line. All the cultured broth of the strains were tested at
a ﬁxed concentration 500µg/mL. Each experiment was repeated 3
times, and the inhibitory ratio was the average of the 3 results.
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Figure 2: 24 strains with best antioxidant activity in DPPH·
assay. All the cultured broths of the strains were tested at a ﬁxed
concentration 375µg/mL. Each experiment was repeated 3 times,
and the inhibitory ratio was the average of the 3 results.
cyclo (Pro-Leu) et al., and (3) the secondary metabolites
isolated from diﬀerent strains signify the diﬀerent metabolite
mechanisms between the genus and the strains.
From the secondary metabolites of our ﬁnding, another
important kind of the metabolites is macrolide. In 2007,
our group found a new macrolactin named macrolactin Q
which was isolated from a marine Bacillus subtilis [11, 12],
and besides, we also isolated macrolactin A and macrolactin
B from the same marine Bacillus subtilis.M a c r o l a c t i nQ ,
macrolactin A and macrolactin B all exhibited antimicrobial
activity, macrolactin Q showing stronger antibacterial activ-
ity against E. coli than S. aureus and B. subtilis.M a c r o l a c t i n
Q inhibited bacterial growth against E.coli with a MIC of
0.2µg/mL, while inhibiting weaker bacterial growth against
S. aureus and B. subtilis with a MIC of 0.7µg/mL and
100µg/mL, respectively.
4. Discussion
According to the diﬀerent sampling points and the diﬀerent
characteristics (morphous, sizes, and colours) of the pure
strains, we totally obtained about 30000 pure strains, of
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Figure 3: 30 strains with best antioxidant activity in ABTS·+
assay. All the cultured broths of the strains were tested at a ﬁxed
concentration 375µg/mL. Each experiment was repeated 3 times,
and the inhibitory ratio was the average of the 3 results.
which 52% strains belong to the actinomycete, 15% belong
to the fungus, and 33% are bacteria. Firstly, we picked up 416
isolated bacteria according to their diﬀerent morphologic
and cultural characteristics to further study their taxonomy,
biological activities, and secondary metabolites.
Based on the morphologic and cultural characteristics
of the strains, ﬁrstly, it is known that majority of them
belong to the Gram-negative bacteria. Secondly, more than
85% strains must be cultured in the medium with diﬀerent
concentrations of NaCl, the concentrations of NaCl which
range from 2.5% to 15%. Thirdly, it is shown that these
strains only need simple nutritional requirements, most
of which possess extracellular enzymes and do not use
sugar as carbon source and so on. Besides, 395 strains
can be determined their taxonomic status, which belong to
33 diﬀerent genera, and Sulﬁtobacter, Halomonas, Bacillus,
Pseudoalteromonas,a n dIdiomarina were the most dominant
species.
In the recent years, there are many studies about the bio-
logical activities of the secondary metabolites isolated from
the marine microorganisms, and these studies mainly focus
on the antibacterial, cytotoxic, antioxidation, and antiviral,
immunosuppressant activities [13]. In our screening pro-
gram for bioactive principles from marine microorganisms,
it is essential to study the biological activities of the marine
microorganisms producing the bioactive secondary metabo-
lites. We mainly studied the activity screening of marine
microorganisms referring to the antimicrobial, cytotoxicity,
and antioxidant activities.
On the large-scale activity screening of the 395 strains,
100 strains possess diﬀerent biological activities, of which
45 strains have antibacterial activities, 63 strains have cyto-
toxicity activities, and 24 strains have antioxidant activities.
By this screening, we found that the microorganisms of
East China Sea have a wide range of biological activities,
including antibacterial activities, cytotoxicity activities, and
antioxidant activities, which possess the good potential for
the development and utilization. It is good for us to further
develop the medicinal microbial use of East China Sea on the6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: The new secondary metabolites and the compounds with the good biological activities isolated from the strain F201721, F81612,
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Table 4: Overview of the 6 strains with biological activities.
No. Genus Biological activity Main type of the secondary metabolites
F81612 Bacillus Antibacterial cyclopeptide, indole derivatives, and macrolide
F201721 Bacillus Antibacterial cyclopeptide, indole derivatives, and macrolide
F8712 Pseudoalteromonas Cytotoxicity cyclopeptide
F321122 Pseudoalteromonas Cytotoxicity cyclopeptide and indole derivatives
F121122 Sulﬁtobacter Cytotoxicity cyclopeptide
M44 Sulﬁtobacter Cytotoxicity cyclopeptide
foundation of the biological activity screening of the isolated
pure strains.
In our screening program for bioactive principles from
marine microorganisms, diketopiperazine and macrolide
are the two important bioactive secondary metabolites.
Diketopiperazines (DKPs), the smallest cyclic peptides, have
been isolated from marine microorganisms (bacteria, fungi,
andactinomycete)[14–17]orthemicroorganismsassociated
with sponge [18–20]. As cyclic peptide derivatives, DKPs
have been considered as cell-cell signalling compounds.
Some L, L-diketopiperazines have recently been known as
quorum-sensing bacterial sensors [21, 22], which are used
by Gram-negative bacteria for cell-cell communication and
regulating geneexpression inresponse topopulation density.
For example, cyclo (L-Pro-L-Phe) and cyclo (L-Pro-L-Leu)
are capable of activating or antagonizing LuxR-mediated
quorum-sensing system of bacteria [23, 24]. Therefore, the
diketopiperazines, which were produced by many species
of the microorganisms, suggest a probable role of these
compounds in bacterial-bacterial interaction.
Besides, DKPs represent an important class of biolog-
ically active natural products, which play an important eco-
logical role in antifouling [25, 26], antifungal [27]a n da n -
tibacterial [16]. For example, cyclo (D-Pro-D-Phe) was pre-
viously found in marine bacteria associated with Pecten
maximus and proved to exhibit bioactivity against Vibrio
anguillarum [16], and meanwhile, it was also proved to
have antifouling activity [28]. Cyclo (L-Pro-L-Phe) and
cyclo-(L-Pro-L-Leu), isolated from the bacterium Alcaligenes
faecalis A72, showed moderate inhibitory activity against S.
aureus [29]. Therefore, the diketopiperazines, which were
isolated from the microorganisms of East China Sea, may
show many kinds of biological activities, which indicated the
biological activities of the microorganisms.
Macrolactins are a group of 24-membered lactones
with potent antibacterial or other activities, most of which
were derived from the second metabolites of the marine
microorganisms, while several of them were also produced
by some soil microorganisms as well. There were total
22 isolated macrolactins reported, since the ﬁrst one was
isolated in 1989. Our group found a new macrolactin named
macrolactin Q, which possesses strong antibacterial activity
against E. coli than S. aureusEvidence-Based Complementary and Alternative Medicine 7
5. Conclusion
The East China Sea marine microorganism library (during
2006–2010) was established for the ﬁrst time, which stored
about 30000 strains that covered most kinds of the species.
In this paper, 395 strains were mainly described, which
belong to 33 diﬀerent genera. Sulﬁtobacter, Halomonas,
Bacillus, Pseudoalteromonas,a n dIdiomarina were the most
dominant species, which may signify the genera diversity
of the microorganisms of East China Sea. According to the
results, 25.3% strains possess diﬀerent biological activities,
likeantibacterial,cytotoxicity,andantioxidant activities.The
diversity of the species of microorganisms, the biological
activities of their secondary metabolites, and the abundant
structure type of the secondary metabolites all indicate that
East China Sea is a potent microorganism-derived medical
resource for drug development.
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